Bridges Investment Management Inc. acquired a new stake in Aflac Incorporated (NYSE:AFL – Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm acquired 2,506 shares of the financial services provider’s stock, valued at approximately $259,000.
Several other hedge funds and other institutional investors have also made changes to their positions in the stock. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its stake in shares of Aflac by 6.4% in the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 4,694,511 shares of the financial services provider’s stock valued at $524,846,000 after buying an additional 281,148 shares during the period. Guinness Asset Management LTD boosted its stake in shares of Aflac by 5.2% in the 4th quarter. Guinness Asset Management LTD now owns 2,395,045 shares of the financial services provider’s stock valued at $247,682,000 after buying an additional 118,720 shares during the period. National Pension Service boosted its stake in shares of Aflac by 8.9% in the 3rd quarter. National Pension Service now owns 1,662,514 shares of the financial services provider’s stock valued at $185,869,000 after buying an additional 136,238 shares during the period. Assetmark Inc. boosted its stake in shares of Aflac by 0.7% in the 3rd quarter. Assetmark Inc. now owns 1,584,552 shares of the financial services provider’s stock valued at $177,153,000 after buying an additional 10,487 shares during the period. Finally, Barclays PLC boosted its stake in shares of Aflac by 10.1% in the 3rd quarter. Barclays PLC now owns 1,391,127 shares of the financial services provider’s stock valued at $155,529,000 after buying an additional 127,911 shares during the period. Hedge funds and other institutional investors own 67.44% of the company’s stock.
Wall Street Analyst Weigh In
Several equities analysts have recently issued reports on the company. Piper Sandler decreased their price objective on Aflac from $122.00 to $118.00 and set an “overweight” rating for the company in a research note on Friday, February 7th. Evercore ISI decreased their target price on Aflac from $104.00 to $102.00 and set an “underperform” rating for the company in a research note on Wednesday, December 4th. Wells Fargo & Company decreased their target price on Aflac from $104.00 to $102.00 and set an “equal weight” rating for the company in a research note on Wednesday, February 19th. Barclays decreased their target price on Aflac from $98.00 to $95.00 and set an “underweight” rating for the company in a research note on Friday, February 7th. Finally, JPMorgan Chase & Co. boosted their target price on Aflac from $90.00 to $94.00 and gave the stock a “neutral” rating in a research note on Tuesday, January 7th. Two analysts have rated the stock with a sell rating, eleven have issued a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $103.36.
Aflac Trading Up 0.5 %
AFL opened at $110.00 on Tuesday. The firm has a market cap of $61.11 billion, a price-to-earnings ratio of 11.46, a price-to-earnings-growth ratio of 3.24 and a beta of 0.99. Aflac Incorporated has a 52 week low of $78.62 and a 52 week high of $115.50. The business’s 50 day moving average is $104.71 and its two-hundred day moving average is $107.65. The company has a quick ratio of 0.08, a current ratio of 0.10 and a debt-to-equity ratio of 0.29.
Aflac (NYSE:AFL – Get Free Report) last released its quarterly earnings results on Wednesday, February 5th. The financial services provider reported $1.56 EPS for the quarter, missing the consensus estimate of $1.63 by ($0.07). Aflac had a return on equity of 16.20% and a net margin of 28.76%. On average, research analysts predict that Aflac Incorporated will post 6.88 EPS for the current year.
Insider Activity
In other news, EVP Audrey B. Tillman sold 24,744 shares of the business’s stock in a transaction that occurred on Friday, December 27th. The stock was sold at an average price of $103.40, for a total value of $2,558,529.60. Following the transaction, the executive vice president now owns 222,618 shares of the company’s stock, valued at approximately $23,018,701.20. The trade was a 10.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Corporate insiders own 0.90% of the company’s stock.
Aflac Company Profile
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.
Recommended Stories
- Five stocks we like better than Aflac
- Health Care Stocks Explained: Why You Might Want to Invest
- Bearish Investors Can Seek Refuge in Recession-Resistant ETFs
- What Makes a Stock a Good Dividend Stock?
- 3 Oversold Magnificent Seven Stocks at Key Levels: Buy Now?
- What is the S&P 500 and How It is Distinct from Other Indexes
- 3M to Hit $175 by Mid-Year, and Higher Highs Are Likely
Want to see what other hedge funds are holding AFL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aflac Incorporated (NYSE:AFL – Free Report).
Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.